BIOA
BioAge Labs
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Key Stats
--DAY`S RANGE--
--52 WK RANGE--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
About BIOA
Bioage Labs, Inc.
A biotech company focused on assessing and optimizing biological age
1445A South 50th Street, Richmond, California 94804
--
BioAge Labs, Inc., was incorporated in Delaware on April 1, 2015. They are a clinical-stage biopharmaceutical company developing product candidates for the treatment of metabolic diseases such as obesity by targeting the biology of human aging. Their technology platform and differentiated human datasets allow them to identify promising targets based on insights into the molecular changes that drive aging. Their main focus is metabolic disease, one of the biggest healthcare challenges in the world.
Company Financials
EPS
BIOA has released its 2024 Q4 earnings. EPS was reported at -1.40, versus the expected -0.66, missing expectations. The chart below visualizes how BIOA has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
